Article
[Hematopoietic cell transplantation in the era of genome analysis].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2026
Nannya Yasuhito
Abstract excerpt
Genomic information for hematologic malignancies is now routinely available in clinical practice, supporting the adaptation of hematopoietic cell transplantation, selection of conditioning intensity, and implementation of post-transplant maintenance therapy through refinement of disease risk assessment and minimal residual disease (MRD) measurement. This review presents the current evidence on the effective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
